Navigation Links
Onyx Pharmaceuticals Provides Status Update on Carfilzomib
Date:10/7/2010

EMERYVILLE, Calif., Oct. 7 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will delay its New Drug Application (NDA) filing for carfilzomib based on a recent meeting with the Chemistry, Manufacturing and Controls (CMC) review division of the U.S. Food and Drug Administration (FDA).  The FDA has requested additional CMC information related to commercial-scale manufacturing of carfilzomib.  Onyx had previously anticipated filing an NDA by the end of 2010 for accelerated approval of carfilzomib and now expects that its NDA filing for accelerated approval could occur as early as mid-year 2011.

The clinical profile of carfilzomib has not changed, and no new safety signals have been observed. The Phase 3 trials are on schedule and actively enrolling patients, and this change is not expected to impact any of the carfilzomib trials or other development plans.

In preparation for commercial-scale production, the company made manufacturing process enhancements in the production of carfilzomib, which are customary when migrating from clinical to commercial-scale manufacturing.  In a recently completed manufacturing-scale run, the company observed minor variations that are believed to be primarily related to equipment temperature variances.  In response to FDA's request, Onyx is providing the agency with additional CMC information.  Onyx has additional data and is generating more information to share as part of the ongoing dialogue with the CMC review division in preparation for an NDA filing.

"We are confident in the clinical and preclinical data package supporting the carfilzomib NDA and in our manufacturing strategy," said N. Anthony Coles, M.D., president and chief executive officer of Onyx. "We believe that by providing this supportive data, we will strengthen our NDA package, thus enabling us to bring carfilzom
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014 MiMedx Group, Inc. (NASDAQ: ... and marketer of patent protected regenerative biomaterials and ... that it has entered into a distribution agreement ... provide its dehydrated human amnion/chorion membrane ("dHACM") allograft ... on a private label basis. The ...
(Date:9/18/2014)... ANN ARBOR, Mich. , Sept. 18, 2014 /PRNewswire-USNewswire/ ... Medical Research will allow the University of Michigan to ... The Glenn Center for Aging Research ... growing evidence that drugs can slow the effects of ... to unlock mechanisms of aging that can help develop ...
(Date:9/18/2014)... announces the list of stocks featured in the Analyst ... the latest news and events impacting stocks and the ... Avanir Pharmaceuticals (Nasdaq: AVNR - Free Report ), ... Orexigen (Nasdaq: OREX - Free Report ), Medivation ... (Nasdaq: GILD - Free Report ). ...
Breaking Medicine Technology:MiMedx Signs Distribution Agreement With Zimmer 2MiMedx Signs Distribution Agreement With Zimmer 3$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 2The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 4The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 5The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 6
... ANGELES, Sept. 29, 2011 A west coast secret is ... All the way from Beverly Hills, California, a health and ... headlines ( www.endlessyouthandlife.com ).  A clinically tested dietary supplement is ... shown in less than 4 weeks of use.  Just a ...
... Awarepoint Corporation , the leading provider ... announced today that it received Frost & Sullivan,s ... Strategy Leadership Award .  The award recognizes ... and workflow automation solutions that significantly differentiates Awarepoint ...
Cached Medicine Technology:Beverly Hills Secret Now Helping People Across The Country 2Awarepoint Corporation Receives Frost & Sullivan's 2011 North American RFID and RTLS Healthcare Competitive Strategy Leadership Award 2Awarepoint Corporation Receives Frost & Sullivan's 2011 North American RFID and RTLS Healthcare Competitive Strategy Leadership Award 3
(Date:9/18/2014)... Relias Learning, the leader in SaaS-based training and ... announced it has been named to the Inc. 5000 list ... , In the three-year period from 2010 to 2013, Relias ... on the Inc. 5000 list to 1,025 from the company’s ... we serve continue to grow, and the need for quality ...
(Date:9/18/2014)... PlatinumCode, a leading manufacturer and ... for the healthcare industry, announced earlier this month ... of their profits of the sale of eligible ... the announcement, PlatinumCode has launched various marketing efforts ... and hospital labs with their popular “Pink Packs” ...
(Date:9/18/2014)... “Awesome” is the way Emily W. describes ... Today) Internship Program at ARDX ( http://www.ardx.net ). ... program as “Inspirational” and “Life-changing,” respectively. None of ... would be doing during their summer internship. Stacie ... other mindless tasks,” but, instead she was doing real, ...
(Date:9/18/2014)... HealthDay Reporter WEDNESDAY, Sept. ... number of post-traumatic stress disorder symptoms are almost three times ... study suggests. The findings don,t prove a direct ... food. And it,s also possible that certain women are prone ... Still, the research seems to add to existing evidence ...
(Date:9/18/2014)... Fit Body Boot Camp , an internationally ... the country and its popularity, as both a franchise and ... in 2014. , The company’s annual business conference, the ... Costa Mesa, CA on September 26 and 27, and is ... Bedros Keuilian, who is also considered the leading fitness marketing ...
Breaking Medicine News(10 mins):Health News:Relias Learning Named to Inc. 5000 List for Second Consecutive Year 2Health News:PlatinumCode Commits to Donating Five Percent of Profits from the sale of Pink Products to Support Breast Cancer Awareness 2Health News:ARDX Internship Helps Students to START on the Right Business Path 2Health News:ARDX Internship Helps Students to START on the Right Business Path 3Health News:ARDX Internship Helps Students to START on the Right Business Path 4Health News:PTSD Link to Food Addiction Seen in Report 2Health News:PTSD Link to Food Addiction Seen in Report 3Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 2Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 3
... MONDAY, Oct. 31 (HealthDay News) --,The longer they live in ... immigrants will develop health problems, a new study says. ... Nutrition Examination Survey and discovered a dramatic increase in obesity, ... in the United States for more than 20 years. ...
... developed a new way to assess a common cause ... Disease Activity Index. A study describing the index was ... Annual Scientific Meeting and Postgraduate Course in Washington. The ... severity. "Until now, physicians have not ...
... on nutrients carried to them by the blood stream. ... hallmark of cancer, and studies have shown that preventing ... To better understand the relationship between cancer and the ... of the complete network of blood vessels in organs. ...
... Tech-savvy teens with acne used their medicine more frequently ... a new study from Wake Forest Baptist Medical Center ... test whether a weekly Internet-based communication could improve teenagers, ... "Dermatologists have a number of effective topical agents for ...
... Surgeons at UK HealthCare recently became the first ever to ... transplantation. Wanda Craig, of Lexington, Ky., is the first patient ... of 68, she is also the oldest living human to ... known as an extracorporeal membrane oxygenation (ECMO). For more ...
... could help GPs to speed up the diagnosis and ... common forms of cancer, potentially saving thousands of lives ... and ClinRisk Ltd have shown that the algorithm is ... lung cancer at an earlier stage by ,red-flagging, potentially ...
Cached Medicine News:Health News:Life in U.S. Not Always a Plus for Immigrants' Health 2Health News:The power of the Internet: It helps improve teens' acne 2Health News:UK HealthCare surgeons are first to perform novel procedures prior to transplant 2Health News:UK HealthCare surgeons are first to perform novel procedures prior to transplant 3Health News:Computer-based tool to improve diagnosis and prognosis for cancer patients 2Health News:Computer-based tool to improve diagnosis and prognosis for cancer patients 3Health News:Computer-based tool to improve diagnosis and prognosis for cancer patients 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: